Related references
Note: Only part of the references are listed.Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction, and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis
Pietro Ameri et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2022)
How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction?: A Redefinition of Evidence-Based Medicine
John J. V. McMurray et al.
CIRCULATION (2021)
Heart failure drug treatment: the fantastic four
Johann Bauersachs
EUROPEAN HEART JOURNAL (2021)
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology
Giuseppe M. C. Rosano et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Drug Layering in Heart Failure Phenotype-Guided Initiation
Giuseppe M. C. Rosano et al.
JACC-HEART FAILURE (2021)
Contemporary Pillars of Heart Failure with Reduced Ejection Fraction Medical Therapy
Eldad Rahamim et al.
JOURNAL OF CLINICAL MEDICINE (2021)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Theresa A. McDonagh et al.
EUROPEAN HEART JOURNAL (2021)
Heart failure drug titration, discontinuation, mortality and heart failure hospitalization risk: a multinational observational study (US, UK and Sweden)
Gianluigi Savarese et al.
EUROPEAN JOURNAL OF HEART FAILURE (2021)
Medical treatment of heart failure with reduced ejection fraction: the dawn of a new era of personalized treatment?
Pietro Ameri et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2021)
Early Effects of Starting Doses of Enalapril in Patients with Chronic Heart Failure in the SOLVD Treatment Trial
Phillip H. Lam et al.
AMERICAN JOURNAL OF MEDICINE (2020)
Estimating lifetime benefits of comprehensive disease -modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
Muthiah Vaduganathan et al.
LANCET (2020)
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Paul W. Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cancer Mortality in Trials of Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis
Giacomo Tini et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction
Javed Butler et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
An empirical comparison of Bayesian modelling strategies for missing binary outcome data in network meta-analysis
Loukia M. Spineli
BMC MEDICAL RESEARCH METHODOLOGY (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis
Michel Komajda et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment
Martin R. Cowie et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction A Network Meta-Analysis
Heather Burnett et al.
CIRCULATION-HEART FAILURE (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey
Michel Komajda et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Falling Cardiovascular Mortality in Heart Failure With Reduced Ejection Fraction and Implications for Clinical Trials
Christopher J. Rush et al.
JACC-HEART FAILURE (2015)
Effects of Spironolactone on Long-term Mortality and Morbidity in Patients With Heart Failure and Mild or No Symptoms
Enrico Vizzardi et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Evaluating the Quality of Evidence from a Network Meta-Analysis
Georgia Salanti et al.
PLOS ONE (2014)
A matrix-based method of moments for fitting the multivariate random effects model for meta-analysis and meta-regression
Dan Jackson et al.
BIOMETRICAL JOURNAL (2013)
Evidence Synthesis for Decision Making 2: A Generalized Linear Modeling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials
Sofia Dias et al.
MEDICAL DECISION MAKING (2013)
Demystifying trial networks and network meta-analysis
Edward J. Mills et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure
B Pitt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Effects of initiating carvedilol in patients with severe chronic heart failure - Results from the COPERNICUS study
H Krum et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Share Paper
